Cargando…

Targeting mitochondrial quality control of T cells: Regulating the immune response in HCC

Most of the primary hepatocellular carcinoma (HCC) develops from Viral Hepatitis including Hepatitis B virus, Hepatitis C Virus, and Nonalcoholic Steatohepatitis. Herein, T cells play crucial roles combined with chronic inflammation and chronic viral infection. However, T cells are gradually exhaust...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Yixue, Gao, Binghong, Zhang, Xue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539266/ https://www.ncbi.nlm.nih.gov/pubmed/36212470 http://dx.doi.org/10.3389/fonc.2022.993437

Ejemplares similares

Immune Checkpoint Inhibitors in the Treatment of HCC
por: Donisi, Clelia, et al.
Publicado: (2021)

A novel HCC prognosis predictor PDSS1 affects the cell cycle through the STAT3 signaling pathway in HCC
por: Rao, Zuqin, et al.
Publicado: (2022)

Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4
por: He, Xi, et al.
Publicado: (2021)

Targeting BET Proteins With a PROTAC Molecule Elicits Potent Anticancer Activity in HCC Cells
por: Zhang, Huapeng, et al.
Publicado: (2020)

Splenic Volume, an Easy-To-Use Predictor of HCC Late Recurrence for HCC Patients After Hepatectomy
por: Fang, Tongdi, et al.
Publicado: (2022)

Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2019)

Efficacy and Safety of SBRT Combined With Camrelizumab and Apatinib in HCC Patients With PVTT: Study Protocol of a Randomized Controlled Trial
por: Hu, Yue, et al.
Publicado: (2020)

Mitochondrial Quality Control in Hepatocellular Carcinoma
por: Bian, Jinda, et al.
Publicado: (2021)

SLC1A4: A Powerful Prognostic Marker and Promising Therapeutic Target for HCC
por: Peng, Xiaozhen, et al.
Publicado: (2021)

Corrigendum: Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2020)

Kill and Clearance in HCC: An Approach Based on NK Cells and Macrophages
por: Mehrabi, Maryam, et al.
Publicado: (2021)

Withaferin A Acts as a Novel Regulator of Liver X Receptor-α in HCC
por: Shiragannavar, Varsha D., et al.
Publicado: (2021)

Study on the changes of CT texture parameters before and after HCC treatment in the efficacy evaluation and survival predication of patients with HCC
por: Zhou, Wei, et al.
Publicado: (2022)

Cancer Cell-Derived Exosomes Promote HCC Tumorigenesis Through Hedgehog Pathway
por: Li, Li, et al.
Publicado: (2021)

Blood-based biomarkers for immune-based therapy in advanced HCC: Promising but a long way to go
por: Sung, Pil Soo, et al.
Publicado: (2022)

Upregulation of Serum Sphingosine (d18:1)-1-P Potentially Contributes to Distinguish HCC Including AFP-Negative HCC From Cirrhosis
por: Jiang, Yingying, et al.
Publicado: (2020)

Integrated Analysis Revealing the Senescence-Mediated Immune Heterogeneity of HCC and Construction of a Prognostic Model Based on Senescence-Related Non-Coding RNA Network
por: Jiang, Yanan, et al.
Publicado: (2022)

Agonists Specific for κ-Opioid Receptor Induces Apoptosis of HCC Cells Through Enhanced Endoplasmic Reticulum Stress
por: Tan, Mengyuan, et al.
Publicado: (2022)

Expression Levels of Three Key Genes CCNB1, CDC20, and CENPF in HCC Are Associated With Antitumor Immunity
por: Si, Tengfei, et al.
Publicado: (2021)

Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis
por: Li, Xinqiang, et al.
Publicado: (2022)

Cabozantinib for HCC Treatment, From Clinical Back to Experimental Models
por: Deng, Shanshan, et al.
Publicado: (2021)

Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)
por: Zhao, Pin, et al.
Publicado: (2021)

Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT
por: Huang, Wei, et al.
Publicado: (2022)

Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients
por: Chen, Ping, et al.
Publicado: (2022)

Single-Cell RNA-Seq Analysis Reveals Microenvironmental Infiltration of Plasma Cells and Hepatocytic Prognostic Markers in HCC With Cirrhosis
por: Zhang, Siwen, et al.
Publicado: (2020)

Matrix Stiffness-Upregulated MicroRNA-17-5p Attenuates the Intervention Effects of Metformin on HCC Invasion and Metastasis by Targeting the PTEN/PI3K/Akt Pathway
por: Gao, Xiangyu, et al.
Publicado: (2020)

Identification of a novel peptide targeting TIGIT to evaluate immunomodulation of (125)I seed brachytherapy in HCC by near-infrared fluorescence
por: Zeng, Peng, et al.
Publicado: (2023)

Roles of lncRNAs Mediating Wnt/β-Catenin Signaling in HCC
por: Xu, Yating, et al.
Publicado: (2022)

A key driver to promote HCC: Cellular crosstalk in tumor microenvironment
por: Liu, Pengyue, et al.
Publicado: (2023)

Corrigendum: Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients
por: Chen, Ping, et al.
Publicado: (2023)

Immune cells and immune cell-targeted therapy in chronic pancreatitis
por: Zhang, Yu, et al.
Publicado: (2023)

Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational study
por: Fan, Wenzhe, et al.
Publicado: (2022)

Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
por: Hao, Xiaopei, et al.
Publicado: (2021)

The Combination of AFP and “Up-To-Seven” Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients
por: Zhang, Da-li, et al.
Publicado: (2022)

Prediction of early recurrence of HCC after hepatectomy by contrast-enhanced ultrasound-based deep learning radiomics
por: Zhang, Hui, et al.
Publicado: (2022)

The Mechanism of Rac1 in Regulating HCC Cell Glycolysis Which Provides Underlying Therapeutic Target for HCC Therapy
por: Ren, Yin-Xiang, et al.
Publicado: (2022)

Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis
por: De Re, Valli, et al.
Publicado: (2022)

Heterogeneities of Site-Specific N-Glycosylation in HCC Tumors With Low and High AFP Concentrations
por: Zhao, Ting, et al.
Publicado: (2020)

Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review
por: Muscolino, Paola, et al.
Publicado: (2023)

PIWIL1 interacting RNA piR-017724 inhibits proliferation, invasion, and migration, and inhibits the development of HCC by silencing PLIN3
por: Wu, Yi-Jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jrd1jtuqc1bc2gm3tqc32h09cj